Is SpaceX a Better Buy Than the 2 "Magnificent Seven" Stocks It Has Surpassed in Market Cap?

The article argues SpaceX is the preferred long-term growth idea over Tesla, citing Tesla’s $25 billion capex plan, slowing profitability, and rising competition in autonomous driving and robotics. It also highlights Meta’s sharply higher 2026 capex guidance of $125 billion to $145 billion, but says Meta remains the cheapest option with a 17.9 forward P/E versus the S&P 500 at 22.5. Overall, the piece is a valuation-and-capex comparison with a cautious near-term view on Tesla and SpaceX, while favoring Meta as a cheaper cash-generating stock.

Analysis

The market is starting to reprice a new bottleneck regime in AI: not model quality, but physical deployment capacity. That is quietly favorable for suppliers that sit upstream of compute buildout—especially semicap equipment, advanced foundry capacity, and power/thermal infrastructure—while creating a financing and execution risk for companies trying to internalize the whole stack. In that setup, the market is likely to reward visible monetization paths and penalize “science project” capex more than usual over the next 6–18 months.

TSLA looks structurally disadvantaged because its spending is converging with a more crowded innovation landscape, but its end-market payback is still uncertain. The second-order effect is that every dollar diverted into moonshot projects increases the probability of margin compression before productization, which could keep the stock trapped in valuation-decompression mode unless there is a step-change in delivery milestones. MSFT is in a similar category of near-term multiple pressure from elevated investment intensity, but with a much stronger enterprise monetization flywheel; the market may still treat it as a lower-beta beneficiary of AI infrastructure demand.

META is the cleaner expression of the trade because it can absorb a large capex wave without jeopardizing solvency, and any incremental AI return only needs to modestly improve ad ROI or engagement to matter. The consensus is likely underestimating how much cash generation can cushion the spend cycle: if the AI investments fail, the downside is margin compression rather than balance-sheet stress, while success re-rates earnings quickly. The real risk is not absolute capex size, but duration—if returns slip beyond the next 2–4 quarters, the stock can de-rate hard before the market gets proof.

The contrarian view is that the market is over-focusing on capex as a red flag and underweighting the optionality embedded in scale. That said, the dispersion between winners and losers should widen: businesses with externalized infrastructure monetization or dominant distribution are better positioned than those funding speculative hardware ecosystems internally.

Key Decisions for Investors

• Long META vs short TSLA as a 3–6 month pair trade: META has a clearer path to monetizing spend and a lower probability of permanent capital loss; TSLA remains exposed to execution slippage and multiple compression.
• Buy META on 5–8% pullbacks with a 6–12 month horizon: use the market’s capex skepticism to accumulate, targeting a mean reversion to a higher earnings multiple if ad yield or engagement metrics inflect.
• Fade TSLA rallies into optimism around moonshot projects: sell call spreads or use bearish collars over 1–3 months if the stock prices in milestones before evidence of scalable unit economics.
• Prefer MSFT and GOOGL over TSLA for AI exposure: these names have clearer monetization rails and should outperform if AI infrastructure spending remains elevated over the next 2–4 quarters.
• If playing the broader theme, overweight NVDA/TSM on dips rather than capex-heavy end-users: they monetize the buildout regardless of which platform ultimately wins, making the risk/reward more favorable over 6–18 months.